Sensex in red: Adani Power, PNB Housing Finance, Kirloskar Brothers lock in at upper circuit

Sensex in red: Adani Power, PNB Housing Finance, Kirloskar Brothers lock in at upper circuit

Shreya Chaware
/ Categories: Trending, DSIJ News

Some buzzing stocks locked in at their respective upper circuits, defying the subdued market sentiments.

On Friday, the domestic markets remained volatile as Sensex erased morning gains to slide into the negative territory, trading at 51,976.11 levels, down by 0.6 per cent. Even then, some buzzing stocks locked in at their respective upper circuits, defying the subdued market sentiments. 

As investors remained optimistic and chose a stock-specific approach for investment based on Q4FY21 result announcements & news releases, a total of 382 stocks locked in at their respective upper circuits on BSE with nine being Group A stocks while 62 Group B stocks.   

The shares of Hikal Ltd have gained around 15.74 per cent since June 1, 2021, after locking in at its upper circuit for the third consecutive day.  

Adani Group stocks have been on a rise since the beginning of the calendar year with many of the company’s scrips touching an all-time high on the basis of positive growth outlook.  

As investors realise the true potential of the tremendous opportunities that Inflame Appliances has in the home appliances market, its shares are seen buzzing on the bourses, intriguing investors.  

Following is a list of the stocks that locked in at their respective upper circuits on Friday  :

Company name  

LTP (Rs)  

Circuit limit (per cent)  

PNB Housing Finance  

838.75  

10  

Goa Carbon  

375.8  

4.99  

Venus Remedies  

332.35  

4.99  

KIOCL  

294.35  

4.99  

Hikal  

443  

4.99  

Majesco Ltd  

80  

4.99  

Kirloskar Brothers  

451.2  

4.99  

Magma Fincorp  

165.55  

4.98  

Inflame Appliances  

260.15  

4.98  

Adani Power  

105.8  

4.96  

Previous Article Angel Broking hits 5 per cent upper circuit on giving a strong performance in May
Next Article Glenmark Pharma trades flat despite getting USFDA nod for Theophylline ER tablets
Rate this article:
3.3

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR